Randomized, 6-week, placebo-controlled study of treatment for adult attention-deficit/hyperactivity disorder: Individualized dosing of osmotic-release oral system (OROS) methylphenidate with a goal of symptom remission

David W. Goodman, H. Lynn Starr, Yi Wen Ma, Anthony L. Rostain, Steve Ascher, Robert B. Armstrong

Research output: Contribution to journalArticlepeer-review

17 Scopus citations

Fingerprint

Dive into the research topics of 'Randomized, 6-week, placebo-controlled study of treatment for adult attention-deficit/hyperactivity disorder: Individualized dosing of osmotic-release oral system (OROS) methylphenidate with a goal of symptom remission'. Together they form a unique fingerprint.